Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland (HepCOP)

Seidenberg, Arztpraxis A., M.D.

Status: Completed

Conditions: Hepatitis C, Chronic; Opioid-Related Disorders; Substance Abuse Treatment Centers

Study type: Observational

Funder types: Other

Identifiers

NCT00473993

HepCOP Zurich

Details and patient eligibility

About

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts.

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Full description

www.seidenberg.ch/hepcop.pdf

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Medical practices and clinics involved in opioid maintenance treatment in the Kanton of Zurich, Switzerland